Navigation Links
Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year 2009 Results; Teleconference and Webcast to be held on September 8, 2009
Date:9/4/2009

iscovering and developing targeted, receptor-specific small molecule and peptide therapeutics. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin Technologies' website athttp://www.palatin.com.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
2. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
4. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
5. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
6. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
7. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
9. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
10. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
11. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... -- Researchers have discovered a new explanation for differences in ... copies of a certain gene, the more serious the handicap. ... is suspected that it is the amount of copies of ... published in the American Journal of Human Genetics , ... Guy Froyen connected to VIB, a life sciences research institute ...
(Date:12/11/2009)... CAMBRIDGE, Mass., Dec. 11 Gwathmey, ... company specializing in cancer, staph aureus, and cardiovascular ... Pre-clinical Services announced today that Rosalie Dunn, Ph.D., ... Dr. Dunn has over 28 years of experience ... Prior to joining Gwathmey, Dr. Dunn managed ...
(Date:12/10/2009)... Endologix, Inc. (Nasdaq: ELGX ), developer of ... that Dan Lemaitre, former President and CEO of ... effective December 11, 2009. Endologix now has ... Franklin D. Brown, Chairman of the Board, said, ... the Endologix Board of Directors. He has ...
(Date:12/10/2009)... provider of advanced flow measurement, control, and level ... company as Global Level Product Manager effective November ... to enhance market penetration of the level measurement ... Instrument from Lafarge Corp, a manufacturer of building ... and Sales. Bayda will report to Brooks Instrument ...
Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Endologix Appoints Dan Lemaitre to its Board of Directors 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3
... Institute of Standards and Technology (NIST) have combined ... single microchip, a cryogenic sensor and a microrefrigerator. ... and faster precision analysis of materials such as ... upcoming issue of Applied Physics Letters,* the NIST ...
... naturally occurring antibodies contained in, GAMMAGARD LIQUID ... disease, CHICAGO, April 15 The University ... (NYSE: BAX ) today,announced data from a ... [Immune Globulin Intravenous (Human)] (IGIV),marketed as KIOVIG in ...
... April 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,(TSX: ONC, ... Dr.,Chandini Thirukkumaran of the Tom Baker Cancer Centre, ... was presented,today at the American Association for Cancer ... in San Diego, California from April,12-16, 2008., ...
Other Biology Technology:NIST micro sensor and micro fridge make cool pair 2Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease 2Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease 3Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease 4Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease 5Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting 2
(Date:12/11/2009)... weight by eating less and exercising more improved their ... of Medicine in St. Louis. , The results of ... issue of the Journal of the American College ... improvement in four key measures of heart and vascular ... decreased thickness of heart muscle, improved pumping and relaxation ...
(Date:12/11/2009)... German . , Halle/Saale. With increasing ... extinctions, plant communities of many European regions are ... more frequently, whereas rare species are becoming extinct. ... are becoming increasingly similar, but also the phylogenetic ... a loss of uniqueness among European floras, scientists ...
(Date:12/11/2009)... existence of a new, rare inherited retinal disease. Now ... which investigators hope will increase understanding of more common ... 9 issue of the Archives of Ophthalmology . ... area of high-resolution central vision that is needed to ... in more common retinal conditions such as macular degeneration ...
Breaking Biology News(10 mins):Moderate weight loss in obese people improves heart function 2Moderate weight loss in obese people improves heart function 3Europe's flora is becoming impoverished 2Europe's flora is becoming impoverished 3New inherited eye disease discovered 2Cinergy Health Names Dr Margaret Lewin Chief Medical Director 56029 1Cinergy Health Names Dr Margaret Lewin Chief Medical Director 56029 2Stream57 to Webcast PCMA Midwest Chapter Meeting Live on Sept 30th 4937 1Stream57 to Webcast PCMA Midwest Chapter Meeting Live on Sept 30th 4937 2Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 1Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 2Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 3Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 4
... four-legged friend seem equally delighted to see them after five ... tell when time passes. Newly published research from The University ... to answering that very question. , The results of the ... When or How Long Ago, appear in the current issue ...
... study indicates that wild salmon may account for just ... the vast majority of the fish come from hatcheries. ... disastrous decline in the population this year, which will ... commercial and recreational salmon fishing. , The role ...
... PHILADELPHIABuilding on nearly 15 years of biodiversity and ... Natural Sciences today announced formation of its Asia ... protection and sustainable use of environmental resources., , One ... Josephs University in Philadelphia, is with Nanjing University, ...
Other Biology News:Are animals stuck in time? 2Hatchery fish outnumber wild chinook salmon in troubled fall run 2Hatchery fish outnumber wild chinook salmon in troubled fall run 3Hatchery fish outnumber wild chinook salmon in troubled fall run 4Hatchery fish outnumber wild chinook salmon in troubled fall run 5Academy establishes Asia Center to protect the environment 2Academy establishes Asia Center to protect the environment 3Academy establishes Asia Center to protect the environment 4
Rabbit polyclonal to SpUlp2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SNNERQSLSSGSND, corresponding to amino acids 622-635 of Schizosaccharomyces pombe SpUlp2...
Lipid Phosphate Phosphohydrolase 2...
Request Info...
Chicken polyclonal to Thioredoxin domain containing 9 ( Abpromise for all tested applications). Antigen: Full length protein (Human) Entrez Gene ID: 10190 Swiss Protein ID: O14530...
Biology Products: